Crohn's Colitis Professional

Checkpoint Inhibitor Colitis

ReachMD Healthcare Image

This presentation features Michael Kattah, MD, PhD of the University of San Francisco as he discusses Checkpoint Inhibitor Colitis.

  • Overview

    Recorded live at the Crohn's & Colitis West Regional Professional Education Conference at UC Davis April 23, 2022. 

    Target Audience
    This national conference is designed to meet the educational needs of primary care physicians, specialty physicians, nurse practitioners, physician assistants, nurses, and pharmacists interested in IBD.

    Learning Objectives
    By the end of this course, the learner will be able to:

    • Develop a therapeutic approach to patients with moderate-severe ulcerative colitis and Crohn’s Disease
    • Describe a practical approach to treat-to-target and therapy de-escalation in inflammatory bowel disease
    • Provide an overview of mechanisms and efficacy of emerging therapies in inflammatory bowel disease
    • Explain the approach to post-operative Crohn’s disease
    • Review updates to colorectal dysplasia surveillance in inflammatory bowel disease
    • Describe the role of nutrition in inflammatory bowel disease management
    • Identify inflammatory bowel disease sub-populations who may be at risk for suboptimal management 

    Please view the other presentations from this course on the IBD Clinical Hub.

    This conference was accredited for live attendees.

Facebook Comments


We’re glad to see you’re enjoying Crohn's Colitis Professional…
but how about a more personalized experience?

Register for free